Format

Send to

Choose Destination
Mitochondrion. 2017 Sep;36:114-123. doi: 10.1016/j.mito.2017.05.010. Epub 2017 May 24.

Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.

Author information

1
Department of Visual Neuroscience, UCL Institute of Ophthalmology, London EC1V 9EL, United Kingdom.
2
Department of Visual Neuroscience, UCL Institute of Ophthalmology, London EC1V 9EL, United Kingdom; Western Eye Hospital, Imperial College London, United Kingdom.
3
Department of Visual Neuroscience, UCL Institute of Ophthalmology, London EC1V 9EL, United Kingdom; Western Eye Hospital, Imperial College London, United Kingdom. Electronic address: m.cordeiro@ucl.ac.uk.

Abstract

Coenzyme Q10 (CoQ10) is a mitochondrial-targeted antioxidant with known neuroprotective activity. Its ocular effects when co-solubilised with α-tocopherol polyethylene glycol succinate (TPGS) were evaluated. In vitro studies confirmed that CoQ10 was significantly protective in different retinal ganglion cell (RGC) models. In vivo studies in Adult Dark Agouti (DA) rats with unilateral surgically-induced ocular hypertension (OHT) treated with either CoQ10/TPGS micelles or TPGS vehicle twice daily for three weeks were performed, following which retinal cell health was assessed in vivo using DARC (Detection of Apoptotic Retinal Cells) and post-mortem with Brn3a histological assessment on whole retinal mounts. CoQ10/TPGS showed a significant neuroprotective effect compared to control with DARC (p<0.05) and Brn3 (p<0.01). Topical CoQ10 appears an effective therapy preventing RGC apoptosis and loss in glaucoma-related models.

KEYWORDS:

Apoptosis; Glaucoma; Membrane biophysics; Neuroprotection; P-glycoprotein; Retinal ganglion cell

PMID:
28549843
PMCID:
PMC5645575
DOI:
10.1016/j.mito.2017.05.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center